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Abstract 
Ogan ethnic community in Indralaya, Ogan Ilir District, South Sumatra has been used several types of plants, i.e. 
Swietenia mahagoni, Averrhoa carambola, Syzygium samarangense, Musa acuminata, Nymphaea rubra, 
Syzygium polyanthum, and Andrographis paniculata for hypertension medicine. Hypertension is a degenerative 
disease caused by free radical activity in the body. The research aimed to study antioxidant activities from 
antihypertension drug plant. The study began with the extraction of seven types of plants using methanol as a 
solvent. The crude extract was tested for its activity using the 1,1-diphenyl-2-picryllhydrazyl (DPPH) method. The 
methanol extract with the highest antioxidant activity, subsequently examines in vitro antihypertension test using 
the Angiotensin Converting Enzyme (ACE) method. Antioxidant test results showed the methanol extract from 
stem bark of S. samarangense had the highest antioxidant activity with IC50 at 83.06 μg/mL. Antihypertension test 
of methanol extract from stem bark of S. samarangense obtained IC50 by 61.56 μg/mL. Based on the IC50 value, 
stem bark of S. samarangense has potential as a source of antioxidant compounds as well as a source of 
antihypertension compounds. 
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Abstrak (Indonesian) 
Penduduk etnis Ogan di Kecamatan Indralaya, Ogan Ilir, Sumatera Selatan telah 
menggunakan beberapa jenis tumbuhan yaitu mahoni (Swietenia mahagoni), 
belimbing manis (Averrhoa carambola), jambu air (Syzygium samarangense), 
jantung pisang (Musa acuminata), teratai (Nymphaea rubra), daun salam (Syzygium 
polyanthum) and sambiloto (Andrographis paniculata) untuk pengobatan hipertensi. 
Hipertensi adalah penyakit degeneratif yang disebabkan oleh aktivitas radikal bebas 
dalam tubuh. Penelitian ini bertujuan untuk mempelajari aktivitas antioksidan dari 
tumbuhan obat antihipertensi. Ekstrak ketujuh jenis tumbuhan diperoleh dengan 
menggunakan pelarut metanol. Masing-masing ekstrak diuji aktivitas antioksidan 
dengan metode 1,1-difenil-2-pikrillhidrazil (DPPH). Ekstrak metanol yang memiliki 
aktivitas antioksidan paling tinggi, selanjutnya dilakukan uji antihipertensi secara in 
vitro menggunakan metode Angiotensin Converting Enzyme (ACE). Hasil uji 
antioksidan memperlihatkan bahwa ekstrak metanol dari kulit batang S. 
samarangense memiliki aktivitas antioksidan tertinggi dengan IC50 sebesar 83,06 
μg/mL. Uji antihipertensi terhadap ekstrak metanol kulit batang S. samarangense 
diperoleh nilai IC50 sebesar 61,56 μg/mL. Berdasarkan data IC50 tersebut, 
memperlihatkan bahwa kulit batang S. samarangense memiliki potensi sebagai 
sumber senyawa antioksidan sekaligus sumber senyawa antihipertensi. 
Keywords: Syzygium samarangense, kulit batang, antioksidan, antihipertensi 
 
INTRODUCTION 
The research for bioactive compounds from 
traditional medicinal plants was growing, along with 
the number of studies in the field of ethnobotany in 
various ethnicities, especially in Indonesia [1,2,3]. 
The results showed that many plants have been used 
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by the community for the treatment of various 
diseases but have not been supported by adequate 
scientific information [4]. Besides, currently many 
herbal products were sold freely to treat various 
diseases. These herbal products were in great demand 
by the public, arguing that they were cheaper and 
more efficient than modern medicine [5,6,7]. 
The efficacy of a plant as a traditional medicine 
was related to secondary metabolite compounds 
contained in the plant extract which includes 
terpenoids, steroids, flavonoids, phenolic, and 
alkaloids [8,9]. These secondary metabolites have 
varied pharmacological activities as antimicrobial, 
anti-inflammatory, antioxidant, cytotoxic, 
antidiabetic, antihypertension, antitumor, anticancer 
and others [10,11,12]. 
The results of a survey of Ogan ethnic population 
in Indralaya, Ogan Ilir District, and South Sumatra 
found several types of plants that have been used for 
the treatment of hypertension; there are Swietenia 
mahagoni, Averrhoa carambola, Syzygium 
samarangense, Musa acuminata, Nymphaea rubra, 
Syzygium polyanthum, and Andrographis paniculata 
[13]. The use of several kind from antihypertension 
drug plant were expected by related of antioxidant 
activities found in plants. 
Hypertension is a condition of systolic blood 
pressure of more than 140 mmHg and diastolic blood 
pressure of more than 90 mmHg [14]. The role of 
antioxidant compounds in reducing blood pressure for 
hypertension patients was through inhibition of 
enzymes an increase occurred of blood pressure 
[15,16]. In vitro, the test method used for testing 
antihypertension activity was the Angiotensin 
Converting Enzyme (ACE) method [17]. Antioxidants 
from bioactive compounds can inhibit the formation 
of Angiotensin II from Angiotensin I which was 
catalyzed by the enzyme Angiotensin Converting 
Enzyme (ACE) [18,19]. Angiotensin II that was 
formed stimulate aldosterone so that the body 
performs sodium absorption and potassium excretion 
[20,21]. Further analysis was recommended to prove 
antioxidant compounds as candidates for hypertension 
drugs to obtain good scientific information. 
MATERIALS AND METHODS 
Materials and Instrumentation 
The fresh of medicinal plants, which were leave, 
stem bark and fruit of Switenia mahagoni, leave and 
stem bark of Averrhoa carambola, leave and stem 
bark of Syzygium samarangense, rind and flower of 
Musa acuminate, bark and bulbs of Nymphaea rubra, 
leave of Syzygium polyanthum, and leave of 
Andrographis paniculata. The medicinal plants were 
collected in Indralaya area, Ogan Ilir district, South 
Sumatra. Identification carried out at the Botany 
Laboratory, University of Sriwijaya. The 
measurement of antioxidant activity was carried out at 
the Joint Basic Laboratory, Faculty of Mathematics 
and Natural Science, University of Sriwijaya. The 
measurement of antihypertension activity conducted 
at the Research Laboratory of the Department of 
Chemistry, Faculty of Mathematics and Natural 
Science, University of Sriwijaya. Materials needed in 
isolation: technical methanol and Kiessel gel 60 
GF254 TLC plate. Antioxidant activity testing 
reagents: methanol p.a, 1,1-diphenyl-2-picrylhydrazyl 
(DPPH), and ascorbic acid. Reagent testing for 
antihypertension activity: borate buffer pH 8.3, BSA, 
DMSO, HCl, Hippuryl-L-Histidyl-L-Leucine 
substrate (HHL), ACE enzymes, captopril, phosphate 
buffer pH 7. The instrument in this study used 
spectrophotometer UV-Vis Beckman DU-700. 
Methods 
Extraction 
The sample was chopped, dried in the air at room 
temperature to a constant weight and grinded to form 
a fine powder. The sample macerated using methanol 
for 1x24 hours. A maceration was done three times 
and the methanol extract was concentrated with a 
rotary evaporator, to obtain crude methanol extract. 
The all of methanol extract was tested for antioxidant 
activity by the DDPH method. 
Antioxidant activity with the DPPH method 
All of methanol extract was tested for antioxidant 
activity through 0.2 mL of various concentrations of 
sample solution (1000, 500, 250, 125, 62.5 μg/mL) 
was added 3.8 mL of DPPH 0.05 mM solution. The 
mixture of solutions was homogenized and left for 30 
minutes in a dark place. The absorbance was 
measured by a UV-Vis spectrophotometer at λmax 517 
nm. Standard antioxidant solutions used ascorbic acid, 
which was measured by the same treatment as the 
sample. The antioxidant activity of the sample was 
determined by the amount of DPPH radical 
absorbance through calculation of the percentage 
inhibiton of DPPH [22].  
The antioxidant activity of each sample was 
determined by the percentage of free radical inhibition 
(percent inhibition) which can be calculated with the 
following formulation: 
% 𝑖𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛 ൌ  ௔௕௦ ௕௟௔௡௞ି௔௕௦ ௦௔௠௣௟௘௔௕௦ ௕௟௔௡௞ 𝑥 100 %  (1) 
Antihypertension activity test using ACE method 
In vitro measurement of antihypertension activity 
in this study was based on inhibition of the ACE 
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enzyme by the sample [23,24]. The filtrate 80 μL 
methanol extract (sample), captopril (sample control), 
borate buffer (blank and blank control) was added 50 
μL of Hippuryl-L-Histidyl-L-Leucine (HHL) substrate 
(2.5 mM HHL in 0.05 M sodium borate buffer, 
containing 0.15 M NaCl, at pH 8.3) and added 15 μL 
BSA, then the mixture was incubated for 5 minutes at 
37ºC. Sample and blank was added 100 μL ACE, 
sample control and blank control was added 100 μL 
distilled water. The mixture was incubated for 30 
minutes at 37ºC. The reaction was stopped by the 
addition of 250 μL 0.5 M HCl, then vortex for 5 
minutes. The mixture was added 1.5 mL ethyl acetate 
to extract the formed hippuric acid. The mixture was 
then centrifuged at a speed of 10000 rpm for 10 
minutes. The top layer was taken as much as 800 μL 
and dried in an oven at 95 C for 75 minutes. The 
formed hippuric acid was dissolved into 1000 μL 
aqua-bides. Absorbance of hipuric acid was measured 
at λmax 228 nm using UV-Vis spectrophotometer.  
Therefore, absorbance data was obtained blank (A), 
control blank (B), sample (C) and blank control 
(D).ACE inhibitor activity is calculated in percent 
form with the formula: 
% 𝐴𝐶𝐸 𝑖𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛 ൌ  ሺ஺ି஻ሻିሺ஼ି஽ሻሺ஺ି஻ሻ 𝑥 100 %   (2) 
Note: 
A= absorbance blank (HHL substrate + ACE enzyme) 
B= absorbance blank control (HHL substrate + aquadest) 
C= absorbance of sample (HHL substrate + sample + ACE 
enzyme) 
D= absorbance of sample control (HHL substrate + 
captopril + aquadest) 
RESULTS AND DISCUSSION 
The methanol extracts of the seven plant by parts 
used in Ogan people as a hypertension drug were 
tested for their antioxidant activity as shown in Table 
1-3. 
 
 The data shown in Table 1-3 shows that Syzygium 
samarangense, Switenia mahagoni, and Averrhoa 
carambola provide high antioxidant activity. Based 
on the IC50 value, the methanol extract of S. 
samarangense stem bark was the highest antioxidant 
activity then all of extracts. The antioxidant activity 
from extract was categorized strong (IC50<200 
μg/mL), moderate (IC50 200-1000 μg/mL), and weak 
(IC50>1000 μg/mL) [25]. The IC50 from stem bark of 
S. samarangense was 83.06 μg/mL and categorized as 
strong. 
It was also shown that the graph of the S. 
samarangense stem bark approaches the graph of 
ascorbic acid (Figure 1). Based on the graph, stem 
bark of S. samarangense has very high of potential 
antioxidant. At the same concentration (250 μg/mL), 
stem bark of S. samarangense and ascorbic acid have 
been the same of percent inhibition value at the 80 % 
inhibition. 
Table 1. Absorbance values of parts of medicinal plants in testing antioxidant activity by DPPH method 
Concentration 
(μg/mL) 
Leave of 
Switenia 
mahagoni 
Leave of 
Syzygium 
samarangense 
Flower of 
Musa 
acuminata 
Bark of 
Nymphaea 
rubra 
Bulbs of 
Nymphaea 
rubra 
Rind of 
Musa 
acuminata 
Fruit of 
Switenia 
mahagoni 
DPPH 0.953 0.928 0.928 0.928 0.953 0.953 0.953 
62.5 0.702 0.664 0.924 0.915 0.917 0.921 0.644 
125 0.415 0.420 0.924 0.912 0.901 0.903 0.521 
250 0.078 0.128 0.920 0.899 0.867 0.877 0.412 
500 0.064 0.067 0.821 0.892 0.817 0.855 0.092 
1000 0.054 0.055 0.819 0.892 0.811 0.853 0.063 
 
Concentration 
(μg/mL) 
Leave of 
Averrhoa 
carambola 
Leave of 
Syzygium 
polyanthum 
Stem bark of 
Switenia 
mahagoni 
Stem bark of 
Averrhoa 
carambola) 
Leave of 
Andrographis 
paniculata 
Stem bark of 
Syzygium 
samarangense 
Ascorbic 
acid 
DPPH 0.953 0.953 0.953 0.928 0.928 0.928 0.953 
62.5 0.897 0.633 0.556 0.672 0.814 0.912 0.314 
125 0.865 0.439 0.402 0.353 0.715 0.532 0.254 
250 0.701 0.104 0.132 0.124 0.451 0.232 0.208 
500 0.456 0.089 0.131 0.117 0.318 0.099 0.040 
1000 0.087 0.089 0.130 0.114 0.099 0.062 0.034 
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Table 2. % inhibition value of parts from medicinal plants in testing antioxidant activity by DPPH method 
Concentration 
(μg/mL) 
Leave of 
Switenia 
mahagoni 
Leave of 
Syzygium 
samarangense 
Flower of 
Musa 
acuminata 
Bark of 
Nymphaea 
rubra 
Bulbs of 
Nymphaea 
rubra 
Rind of 
Musa 
acuminata 
Fruit of 
Switenia 
mahagoni 
62.5 24.35 28.45 0.431 1.4 1.18 3.45 32.42 
125 55.28 54.74 0.431 1.72 2.91 5.39 45.33 
250 91.59 86.21 0.86 3.12 6.57 8.19 56.77 
500 93.1 92.78 11.53 3.88 11.96 10.56 90.33 
1000 94.18 94.07 11.73 3.88 12.61 12.61 93.39 
Concentration 
(μg/mL) 
Leave of 
Averrhoa 
carambola 
Leave of 
Syzygium 
polyanthum 
Stem bark of 
Switenia 
mahagoni 
Stem bark of 
Averrhoa 
carambola 
Leave of 
Andrographis 
paniculata 
Stem bark of 
Syzygium 
samarangense 
62.5 5.876 36.51 44.68 39.02 21.28 10.59 
125 9.23 55.97 60 67.97 30.85 47.84 
250 26.44 89.57 86.86 88.75 56.38 77.25 
500 52.15 91.07 86.96 89.38 69.24 90.29 
1000 90.87 91.07 87.06 89.65 90.42 93.92 
 
Table 3. IC50 values of parts of medicinal plants in testing antioxidant activity by DPPH method 
Test 
Sample 
IC50 
(μg/mL) 
Leave of Switenia mahagoni (LSM) 125.55 
Leave of Syzygium samarangense (LSS) 124.3 
Flower of Musa acuminata (FMA) 19.913 
Bark of Nymphaea rubra (BaNR) 5.189 
Bulbs of Nymphaea rubra (BuNR) 2.091 
Rind of Musa acuminata (RMA) 3.469 
Fruit of Switenia mahagoni (FSM) 185.74 
Test 
Sample 
IC50 
(μg/mL)
Leave of Averrhoa carambola (LAC) 529.76 
Leave of Syzygium polyanthum (LSP) 107.79 
Stem bark of Switenia mahagoni (SSM) 83.89 
Stem bark of Averrhoa carambola (SBC) 85.10 
Leave of Andrographis paniculata (LAP) 285.40 
Stem bark of Syzygium samarangense (SSS) 83.06 
Ascorbic acid (AA) 22.23 
    
A methanol extract from stem bark of S. 
samarangense (SSS) was carried out in vitro 
antihypertension test with the Angiotensin Converting 
Enzyme (ACE) method. ACE inhibition was one of 
the main classes of antihypertension drugs in reducing 
blood pressure [15]. ACE inhibitors (ACE-I) can 
inhibit converting of ACE enzyme from angiotensin I 
become angiotensin II to given a vasodilation effect 
[26]. A vasodilation effect was the wide of blood 
vessels to reducing blood pressure. Determination of 
ACE activity by Hippuryl-L-Histidyl-L-Leucine 
(HHL) substrate carried out of methanol extracts from 
stem bark of S. samarangense (SSS) was expressed 
from the percent inhibition of ACE (y) and 
concentration (x) in Table 4 and Table 5. 
IC50 ACE values from methanol extract SSS and 
captopril were 61.56 and 0.06 μg/mL. This shows that 
methanol extract stem bark of S. samarangense have 
weak potential to inhibition of ACE enzyme if 
compared to captopril. But, this was supported by 
research reports on several medicinal plants in 
Indonesia. The reports state that the plants have the 
best potential for antihypertension, like that ethanol 
extract from leaves Averrhoa blimbi L; leaves of 
Morinda citrifolia L; leaves of Orthosiphon stamineus 
Benth; leaves of Syzigium polyanthum; and leaves of 
Solanum indicum Linn with a percentage of inhibitor 
activity each of 71.48; 66.64; 55.41; 53,37; and 53.24 
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μg/mL [27]. Therefore, the stem bark of S. 
samarangense methanol extract with IC50 61.56 
μg/mL is also the best potential for antihypertension. 
 
 
Figure 1. The graph between percentage of inhibition and concentration 
 
 
 
Table 4. Value of absorbance and % ACE inhibition 
Concentration 
(μg/mL) Type 
Methanol 
extract SSS Captopril 
A I (%) A I (%) 
6.25 Blank 0.405 20.78 
0.405 
51.20 Sample 0.321 0.198 
12.5 Blank 0.402 25.83 
0.402 
56.66 Sample 0.298 0.174 
25 Blank 0.383 40.76 
0.383 
58.94 Sample 0.227 0.157 
50 Blank 0.374 44.61 
0.378 
63.83 Sample 0.207 0.137 
100 Blank 0.373 66.19 
0.371 
99.43 Sample 0.126 0.002 
Note: A: Absorbance            I: Inhibition 
 
Table 5. IC50 ACE values of methanol extract SSS 
and captopril  
Test Sample IC50(μg/mL)
Methanol extract SSS 61.56 
Captopril 0.06 
The method based on the hydrolysis of the 
Hippuril-Histidil-Leucine (HHL) substrate by the 
ACE enzyme so that it releases hippuric acid and 
Histidil-Leucine (HL). The methanol extract from 
stem bark of S. samarangense thought to have a role 
in inhibiting the action of the ACE enzyme in the 
hydrolysis reaction from hippuril acid to hippuric acid 
[28] shown in Figure 2.  
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Figure 2. Hydrolysis of HHL by ACE to produce hippuric acid and HL 
 
CONCLUSION 
The seven plants that traditionally been used by the 
Ogan ethnic community as a cure for hypertension, 
the stem bark of S. samarangense plant have the 
highest antioxidant activity and potential as an 
antihypertension activity.  
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